Cargando…

Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021

The COVID-19 vaccination programme commenced in England on 8th December 2020 primarily based on age; by 7th March 2021 approximately 93% of the English population aged 70+ years had received at least 1 dose of either the Pfizer BioNTech or AstraZeneca vaccines. Using a nucleoprotein assay that detec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Whitaker, Heather J, Elgohari, Suzanne, Rowe, Cathy, Otter, Ashley David, Brooks, Tim, Linley, Ezra, Hayden, Iain, Ribeiro, Sonia, Hewson, Jacqueline, Lakhani, Anissa, Clarke, Eleanor, Tsang, Camille, Campbell, Colin NJ, Ramsay, Mary, Brown, Kevin, Amirthalingam, Gayatri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Ltd on behalf of The British Infection Association. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110696/ https://www.ncbi.nlm.nih.gov/pubmed/33989631 http://dx.doi.org/10.1016/j.jinf.2021.04.037

Ejemplares similares

Sociodemographic disparities in COVID-19 seroprevalence across England in the Oxford RCGP primary care sentinel network
por: Whitaker, Heather, et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2 antibodies in university students: Cross-sectional study, December 2020, England
por: Vusirikala, Amoolya, et al.
Publicado: (2021)

Following the Omicron wave, the majority of children in England have evidence of previous COVID infection
por: Oeser, C, et al.
Publicado: (2023)

Large increases in SARS-CoV-2 seropositivity in children in England: Effects of the delta wave and vaccination
por: Oeser, Clarissa, et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2 among Blood Donors and Changes after Introduction of Public Health and Social Measures, London, UK
por: Amirthalingam, Gayatri, et al.
Publicado: (2021)

Community seroprevalence of SARS-CoV-2 in children and adolescents in England, 2019–2021
por: Ratcliffe, Helen, et al.
Publicado: (2023)

Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England
por: Amirthalingam, Gayatri, et al.
Publicado: (2021)

Author Correction: Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England
por: Amirthalingam, Gayatri, et al.
Publicado: (2022)

Emergence of SARS-CoV-2 Alpha (B.1.1.7) variant, infection rates, antibody seroconversion and seroprevalence rates in secondary school students and staff: Active prospective surveillance, December 2020 to March 2021, England
por: Ladhani, Shamez N., et al.
Publicado: (2021)

Serological responses to COVID-19 Comirnaty booster vaccine, London, United Kingdom, September to December 2021
por: Ireland, Georgina, et al.
Publicado: (2022)

Characteristics associated with COVID-19 vaccine uptake among adults aged 50 years and above in England (8 December 2020–17 May 2021): a population-level observational study
por: Tessier, Elise, et al.
Publicado: (2022)

Implementation and Extended Evaluation of the Euroimmun Anti-SARS-CoV-2 IgG Assay and Its Contribution to the United Kingdom’s COVID-19 Public Health Response
por: Otter, Ashley David, et al.
Publicado: (2022)

Serogroup C Neisseria meningitidis disease epidemiology, seroprevalence, vaccine effectiveness and waning immunity, England, 1998/99 to 2015/16
por: Findlow, Helen, et al.
Publicado: (2019)

Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction
por: Amirthalingam, Gayatri, et al.
Publicado: (2016)

Burden of varicella complications in secondary care, England, 2004 to 2017
por: Bernal, James Lopez, et al.
Publicado: (2019)

Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response amongst individuals in clinical risk groups
por: Whitaker, Heather J., et al.
Publicado: (2022)

Evaluation of the effect of the herpes zoster vaccination programme 3 years after its introduction in England: a population-based study
por: Amirthalingam, Gayatri, et al.
Publicado: (2017)

Impact of Extending the Timing of Maternal Pertussis Vaccination on Hospitalized Infant Pertussis in England, 2014–2018
por: Tessier, Elise, et al.
Publicado: (2020)

Author Correction: Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection
por: Zuo, Jianmin, et al.
Publicado: (2021)

Real-world data shows increased reactogenicity in adults after heterologous compared to homologous prime-boost COVID-19 vaccination, March−June 2021, England
por: Powell, Annabel A, et al.
Publicado: (2021)

Real-world data on immune responses following heterologous prime-boost COVID-19 vaccination schedule with Pfizer and AstraZeneca vaccines in England
por: Westrop, Samantha J, et al.
Publicado: (2022)

Impact of the herpes zoster vaccination programme on hospitalised and general practice consulted herpes zoster in the 5 years after its introduction in England: a population-based study
por: Andrews, Nick, et al.
Publicado: (2020)

Emergence of the delta variant and risk of SARS-CoV-2 infection in secondary school students and staff: Prospective surveillance in 18 schools, England
por: Ladhani, Shamez N., et al.
Publicado: (2022)

Investigating the pertussis resurgence in England and Wales, and options for future control
por: Choi, Yoon Hong, et al.
Publicado: (2016)

Accelerating Control of Pertussis in England and Wales
por: Campbell, Helen, et al.
Publicado: (2012)

Summer music and arts festivals as hot spots for measles transmission: experience from England and Wales, June to October 2016
por: le Polain de Waroux, Olivier, et al.
Publicado: (2016)

Lessons learnt from the implementation of maternal immunization programs in England
por: Amirthalingam, G., et al.
Publicado: (2016)

Representativeness, Vaccination Uptake, and COVID-19 Clinical Outcomes 2020-2021 in the UK Oxford-Royal College of General Practitioners Research and Surveillance Network: Cohort Profile Summary
por: Leston, Meredith, et al.
Publicado: (2022)

Serological surveillance of SARS-CoV-2: Six-month trends and antibody response in a cohort of public health workers
por: Harris, Ross J., et al.
Publicado: (2021)

The importance of tetanus risk assessment during wound management
por: Collins, Sarah, et al.
Publicado: (2014)

SARS-CoV-2 infection and transmission in primary schools in England in June–December, 2020 (sKIDs): an active, prospective surveillance study
por: Ladhani, Shamez N, et al.
Publicado: (2021)

Antibody persistence and neutralising activity in primary school students and staff: Prospective active surveillance, June to December 2020, England
por: Ireland, Georgina, et al.
Publicado: (2021)

Monitoring the COVID-19 immunisation programme through a national immunisation Management system – England’s experience
por: Tessier, Elise, et al.
Publicado: (2023)

Emergence of a Novel Coronavirus (COVID-19): Protocol for Extending Surveillance Used by the Royal College of General Practitioners Research and Surveillance Centre and Public Health England
por: de Lusignan, Simon, et al.
Publicado: (2020)

Impact of the COVID-19 pandemic on Bordetella pertussis infections in England
por: Tessier, Elise, et al.
Publicado: (2022)

Seroprevalence of Toxoplasma gondii in the Eurasian otter (Lutra lutra) in England and Wales
por: Chadwick, Elizabeth A, et al.
Publicado: (2013)

SARS-CoV-2 infection, antibody positivity and seroconversion rates in staff and students following full reopening of secondary schools in England: A prospective cohort study, September–December 2020
por: Ladhani, Shamez N., et al.
Publicado: (2021)

Oral Fluid Testing for Pertussis, England and Wales, June 2007–August 2009
por: Campbell, Helen, et al.
Publicado: (2014)

Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection
por: Zuo, Jianmin, et al.
Publicado: (2021)

The Burden of Disease and Health Care Use among Pertussis Cases in School Aged Children and Adults in England and Wales; A Patient Survey
por: van Hoek, Albert Jan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_trn8n7loellh82mr73ise45okb